IMDX
Insight Molecular Diagnostics
IMDX
IMDX
52 hedge funds and large institutions have $19.7M invested in Insight Molecular Diagnostics in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 19 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
74% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 19
86% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 7
Holders
52
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$32.1K | |
| 2 | +$11.1K | |
| 3 | +$7.79K | |
| 4 |
BlackRock
New York
|
+$2.47K |
| 5 |
LPL Financial
San Diego,
California
|
+$2.32K |
Top Sellers
| 1 | -$1.38M | |
| 2 | -$171K | |
| 3 | -$143K | |
| 4 |
IA
IFP Advisors
Tampa,
Florida
|
-$98K |
| 5 |
E
Ergoteles
New York
|
-$33K |